A virtual Westminster Health Forum event to discuss the key policy priorities and next steps for improving outcomes in rare diseases and specialised commissioning in England.
The discussion is bringing together stakeholders with key policy officials who are due to attend from the Department of Health and Social Care; the MHRA; the Office for Life Sciences; and The Scottish Government.
Ask for a Free trial and get access to the latest stories
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
an initial 10 day temporary access of APM Health Europe.